Clinical trial
Clot Formation and Clot Stability in Patients With Severe Haemophilia A - Effect of Recombinant Factor VIII and Tranexamic Acid
NCT00279578 is registered in ClinicalTrials.gov with University of Aarhus as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clot Formation and Clot Stability in Patients With Severe Haemophilia A - Effect of Recombinant Factor VIII and Tranexamic Acid
- Lead sponsor
- University of Aarhus
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- June 30, 2006
- Enrollment
- 8
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.